Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
13.7M
-
Shares change
-
+763K
-
Total reported value, excl. options
-
$131M
-
Value change
-
+$7.6M
-
Number of buys
-
36
-
Number of sells
-
-27
-
Price
-
$9.57
Significant Holders of IMMUNIC, INC. - Common Stock (IMUX) as of Q4 2021
81 filings reported holding IMUX - IMMUNIC, INC. - Common Stock as of Q4 2021.
IMMUNIC, INC. - Common Stock (IMUX) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.7M shares
of 120M outstanding shares and own 11.4% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (1.79M shares), RTW INVESTMENTS, LP (1.72M shares), BlackRock Inc. (1.3M shares), Parkman Healthcare Partners LLC (974K shares), VANGUARD GROUP INC (902K shares), Point72 Asset Management, L.P. (725K shares), Artal Group S.A. (700K shares), SPHERA FUNDS MANAGEMENT LTD. (667K shares), MILLENNIUM MANAGEMENT LLC (571K shares), and FMR LLC (509K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.